Summary Medicure Inc (Medicure) is a pharmaceutical company that develops and commercializes human therapeutics. The company’s product includes aggrastat tirofiban HCl, indicated for reducing the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It markets and distributes aggrastat, glycoprotein GP IIb and IIIa receptor antagonist in the US, Puerto Rico, Virgin Islands and Guam. Medicure also develops and commercializes tardoxal. The company offers small molecule drug that is under development for the treatment of neurological conditions such as tardive dyskinesia. Medicure is headquartered in Winnipeg, Manitoba, Canada. Medicure Inc Key Recent Developments May 24,2017: Medicure Reports Financial Results for Quarter Ended March 31, 2017 Apr 26,2017: Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016 Nov 09,2016: Medicure Reports Third Quarter 2016 Financial Results Aug 10,2016: Medicure Reports Second Quarter 2016 Financial Results May 11,2016: Medicure Reports First Quarter 2016 Financial Results This comprehensive SWOT profile of Medicure Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring... Research Beam Model: Research Beam Product ID: 1944151 300 USD New
Medicure Inc (MPH) - Financial and Strategic SWOT Analysis Review
 
 

Medicure Inc (MPH) - Financial and Strategic SWOT Analysis Review

  • Category : Company Profiles
  • Published On : August   2017
  • Pages : 25
  • Publisher : GlobalData
 
 
 
Summary

Medicure Inc (Medicure) is a pharmaceutical company that develops and commercializes human therapeutics. The company’s product includes aggrastat tirofiban HCl, indicated for reducing the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It markets and distributes aggrastat, glycoprotein GP IIb and IIIa receptor antagonist in the US, Puerto Rico, Virgin Islands and Guam. Medicure also develops and commercializes tardoxal. The company offers small molecule drug that is under development for the treatment of neurological conditions such as tardive dyskinesia. Medicure is headquartered in Winnipeg, Manitoba, Canada.

Medicure Inc Key Recent Developments

May 24,2017: Medicure Reports Financial Results for Quarter Ended March 31, 2017
Apr 26,2017: Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016
Nov 09,2016: Medicure Reports Third Quarter 2016 Financial Results
Aug 10,2016: Medicure Reports Second Quarter 2016 Financial Results
May 11,2016: Medicure Reports First Quarter 2016 Financial Results

This comprehensive SWOT profile of Medicure Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Medicure Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents

Section 1 - About the Company

Medicure Inc - Key Information
Medicure Inc - Overview
Medicure Inc - Key Employees
Medicure Inc - Key Employee Biographies
Medicure Inc - Key Operational Heads
Medicure Inc - Major Products and Services
Medicure Inc - History
Medicure Inc - Company Statement
Medicure Inc - Locations And Subsidiaries
Medicure Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Medicure Inc - Business Description
Medicure Inc - Corporate Strategy
Medicure Inc - SWOT Analysis
SWOT Analysis - Overview
Medicure Inc - Strengths
Medicure Inc - Weaknesses
Medicure Inc - Opportunities
Medicure Inc - Threats
Medicure Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Medicure Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
List of Tables

Medicure Inc, Key Information
Medicure Inc, Key Ratios
Medicure Inc, Share Data
Medicure Inc, Major Products and Services
Medicure Inc, History
Medicure Inc, Key Employees
Medicure Inc, Key Employee Biographies
Medicure Inc, Key Operational Heads
Medicure Inc, Other Locations
Medicure Inc, Subsidiaries
Medicure Inc, Key Manufacturing facilities
Medicure Inc, Key Competitors
Medicure Inc, SWOT Analysis
Medicure Inc, Ratios based on current share price
Medicure Inc, Annual Ratios
Medicure Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios List of Figures

Medicure Inc, Performance Chart
Medicure Inc, Ratio Charts
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter